- Home
- PTA vs AORT Comparison
PTA vs AORT Comparison
Compare PTA & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTA
- AORT
- Stock Information
- Founded
- PTA 2020
- AORT 1984
- Country
- PTA United States
- AORT United States
- Employees
- PTA N/A
- AORT N/A
- Industry
- PTA Trusts Except Educational Religious and Charitable
- AORT Medical/Dental Instruments
- Sector
- PTA Finance
- AORT Health Care
- Exchange
- PTA Nasdaq
- AORT Nasdaq
- Market Cap
- PTA 1.1B
- AORT 1.4B
- IPO Year
- PTA N/A
- AORT 1993
- Fundamental
- Price
- PTA $19.76
- AORT $31.13
- Analyst Decision
- PTA
- AORT Strong Buy
- Analyst Count
- PTA 0
- AORT 6
- Target Price
- PTA N/A
- AORT $32.00
- AVG Volume (30 Days)
- PTA 159.2K
- AORT 313.1K
- Earning Date
- PTA 01-01-0001
- AORT 08-07-2025
- Dividend Yield
- PTA 8.31%
- AORT N/A
- EPS Growth
- PTA N/A
- AORT N/A
- EPS
- PTA N/A
- AORT N/A
- Revenue
- PTA N/A
- AORT $390,084,000.00
- Revenue This Year
- PTA N/A
- AORT $12.18
- Revenue Next Year
- PTA N/A
- AORT $10.39
- P/E Ratio
- PTA N/A
- AORT N/A
- Revenue Growth
- PTA N/A
- AORT 5.94
- 52 Week Low
- PTA $15.84
- AORT $21.97
- 52 Week High
- PTA $19.67
- AORT $32.33
- Technical
- Relative Strength Index (RSI)
- PTA 58.15
- AORT 67.53
- Support Level
- PTA $19.39
- AORT $30.32
- Resistance Level
- PTA $19.86
- AORT $31.33
- Average True Range (ATR)
- PTA 0.18
- AORT 0.66
- MACD
- PTA -0.00
- AORT 0.08
- Stochastic Oscillator
- PTA 72.55
- AORT 85.43
About PTA Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund of Beneficial Interest
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.
About AORT Artivion Inc.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.